Literature DB >> 9688413

Vascular endothelial growth factor (VEGF) in endometriosis.

J Donnez1, P Smoes, S Gillerot, F Casanas-Roux, M Nisolle.   

Abstract

Angiogenesis is likely to be involved in the pathogenesis of endometriosis. According to the transplantation theory, when the exfoliated endometrium is attached to the peritoneal layer, the establishment of a new blood supply is essential for the survival of the endometrial implant and development of endometriosis. From the known angiogenic factors, vascular endothelial growth factor (VEGF) has emerged as a pivotally important regulator of normal angiogenesis and pathological neovascularization. The VEGF protein was evaluated immunohistochemically in the eutopic endometrium of 10 women without endometriosis (group I) at laparoscopy and the eutopic endometrium and peritoneal endometriotic lesions of 43 women with endometriosis (group II). VEGF histological scores were 9.7 +/- 4.3 and 4.0 +/- 2.6 respectively in the epithelium and stroma of the eutopic endometrium of group I women, and 10.3 +/- 2.3 and 3.6 +/- 2.3 respectively in women of group II. In red lesions, the VEGF scores were 11.1 +/- 3.0 in the epithelium and 5.1 +/- 3.0 in the stroma, and in black lesions were 8.6 +/- 2.7 and 1.6 +/- 1.6, respectively. Significantly lower values were observed in black lesions as compared with eutopic endometrium and red lesions, the values of which were similar. Scores were also evaluated according to the phase of the cycle. In eutopic as well as ectopic endometrium, no significant cyclic variations were observed throughout the cycle. However, VEGF content was found to be higher in the eutopic glandular epithelium of women with endometriosis during the late secretory phase, possibly suggesting a more likely tendency to implant. In contrast, significantly higher VEGF content was noted in red lesions as compared with black lesions. During all phases of the cycle, the VEGF content in stromal cells of red lesions was higher than in black lesions. Similarities in VEGF content were observed in the glandular epithelium of the eutopic endometrium of women with endometriosis and red lesions, suggesting that endometriosis probably arises from the peritoneal seeding of viable endometrial cells during retrograde menstruation and that red lesions can be considered as the first stage of implantation. After the attachment phase, the high VEGF levels could provoke an increase in the subperitoneal vascular network and facilitate implantation and viability in the retroperitoneal space. Lower VEGF levels in black lesions explain the decrease in both stromal vascularization, followed by fibrosis and inactivation of the implant.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688413     DOI: 10.1093/humrep/13.6.1686

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  76 in total

1.  Secretion of wound healing mediators by single and bi-layer skin substitutes.

Authors:  Manira Maarof; Jia Xian Law; Shiplu Roy Chowdhury; Khairul Anuar Khairoji; Aminuddin Bin Saim; Ruszymah Bt Hj Idrus
Journal:  Cytotechnology       Date:  2016-01-14       Impact factor: 2.058

2.  A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy.

Authors:  Christian M Becker; Renee D Wright; Ronit Satchi-Fainaro; Tae Funakoshi; Judah Folkman; Andrew L Kung; Robert J D'Amato
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

3.  Proangiogenetic molecules, hypoxia-inducible factor-1alpha and nitric oxide synthase isoforms in ovarian endometriotic cysts.

Authors:  Gaia Goteri; Guendalina Lucarini; Antonio Zizzi; Corrado Rubini; Roberto Di Primio; Andrea Luigi Tranquilli; Andrea Ciavattini
Journal:  Virchows Arch       Date:  2010-05-16       Impact factor: 4.064

4.  Everolimus as an mTOR Inhibitor Suppresses Endometriotic Implants: an Experimental Rat Study.

Authors:  T Kacan; C Yildiz; S Baloglu Kacan; M Seker; H Ozer; A Cetin
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-01       Impact factor: 2.915

Review 5.  The endometrial immune environment of women with endometriosis.

Authors:  Júlia Vallvé-Juanico; Sahar Houshdaran; Linda C Giudice
Journal:  Hum Reprod Update       Date:  2019-09-11       Impact factor: 15.610

6.  Slit2 overexpression results in increased microvessel density and lesion size in mice with induced endometriosis.

Authors:  Sun-Wei Guo; Yu Zheng; Yuan Lu; Xishi Liu; Jian-Guo Geng
Journal:  Reprod Sci       Date:  2012-08-08       Impact factor: 3.060

7.  Tyrosine receptor kinase B (TrkB) protein expression in the human endometrium.

Authors:  Dana L Anger; Bingjun Zhang; Odette Boutross-Tadross; Warren G Foster
Journal:  Endocrine       Date:  2007-04       Impact factor: 3.633

8.  Increased immunoreactivity to SLIT/ROBO1 in ovarian endometriomas: a likely constituent biomarker for recurrence.

Authors:  Fanghua Shen; Xishi Liu; Jian-Guo Geng; Sun-Wei Guo
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

9.  2-methoxyestradiol inhibits hypoxia-inducible factor-1{alpha} and suppresses growth of lesions in a mouse model of endometriosis.

Authors:  Christian M Becker; Nadine Rohwer; Tae Funakoshi; Thorsten Cramer; Wanja Bernhardt; Amy Birsner; Judah Folkman; Robert J D'Amato
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

10.  Deficiency of immunophilin FKBP52 promotes endometriosis.

Authors:  Yasushi Hirota; Susanne Tranguch; Takiko Daikoku; Akiko Hasegawa; Yutaka Osuga; Yuji Taketani; Sudhansu K Dey
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.